Skip to main content
. 2018 Apr 2;51(1):150–157. doi: 10.4143/crt.2017.476

Fig. 1.

Fig. 1.

(A-C) Progressive-free survival (PFS) (B) and overall survival (OS) (C) for 60 patients with the analysis of pretreatment Epstein-Barr virus (EBV) DNA status.